Neha Vapiwala, President of American Society for Radiation Oncology (ASTRO), Dean of Admissions at University of Pennsylvania School of Medicine, Professor at University of Pennsylvania, shared ASTRO’s post on LinkedIn, adding:
“High-yield discussion on all things AI impacting radiation oncology. Breadth of perspectives from key stakeholders, including industry, FDA and NCI, underscoring the importance of various American Society for Radiation Oncology (ASTRO) initiatives already underway and new projects to come. RadOnc has a long track record of embracing innovation and harnessing technological advances to improve patient care. Together with American Association of Physicists in Medicine, European Society for Radiotherapy and Oncology (ESTRO) and others, we’re in a critical window to help shape and drive this rapidly evolving era of AI. Thanks to efforts like this, we can! Learn more below Mark Waddle, Carlos Cardenas, Rafe McBeth, Kundan Thind, Indrin Julian Chetty, Jeffrey Buchsbaum, Sanjay Aneja.
Quoting ASTRO’s post:
“Today, ASTRO brought together leaders from industry and across the field for our inaugural AI Roundtable to discuss the evolving role of artificial intelligence in radiation oncology and patient care.
Thank you to Fuse Oncology, Inc., MedLever, Inc., Novartis, Siemens Healthineers and Merck for sponsoring this important conversation.
Learn more about ASTRO’s AI initiatives.
Spring 2026 ASTRO news article: AI in Radiation Oncology: The Postmodern Status Quo.”
Other articles featuring Neha Vapiwala and ASTRO on OncoDaily.